Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (COYA) Revenue
Annual & quarterly revenue history · segment & region breakdown
COYA · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCoya Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Coya Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Coya Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Coya Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
COYA revenue · 4 questionsCOYA's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Coya Therapeutics, Inc. SEC filings · GAAP · Coya Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026